Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

aliskiren MeSH Supplementary Concept Data 2025


MeSH Supplementary
aliskiren
Unique ID
C446481
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C446481
Entry Term(s)
2(S),4(S),5(S),7(S)-N-(2-carbamoyl-2-methylpropyl)-5-amino-4-hydroxy-2,7-diisopropyl-8-(4-methoxy-3-(3-methoxypropoxy)phenyl)octanamid hemifumarate
CGP 060536B
CGP-060536B
CGP060536B
SPP100
Tekturna
rasilez
Pharm Action
Renin Inhibitors
Registry Numbers
502FWN4Q32
C8A0P8G029
Related Numbers
C8A0P8G029
Heading Mapped to
*Amides
*Fumarates
Frequency
955
Note
orally active nonpeptidic renin inhibitor
Source
Hypertension 2002 Jan;39(1):E1-8
Indexing Information
Antihypertensive Agents
Renin
Date of Entry
2014/08/11
Revision Date
2023/06/27
aliskiren Preferred
SPP100 Narrower
2(S),4(S),5(S),7(S)-N-(2-carbamoyl-2-methylpropyl)-5-amino-4-hydroxy-2,7-diisopropyl-8-(4-methoxy-3-(3-methoxypropoxy)phenyl)octanamid hemifumarate Narrower
Tekturna Narrower
CGP 060536B Narrower
rasilez Narrower
page delivered in 0.005s